The National Company Law Appellate Tribunal (NCLAT) hearing regarding Maruti Suzuki India Limited has been adjourned due to time constraints. The hearing, originally scheduled for September 18, 2025, will be rescheduled, with the new date to be announced later. This follows a series of previous adjournments. The company remains committed to providing updates as developments unfold.

NCLAT Hearing Update

The ongoing case involving Maruti Suzuki India Limited before the National Company Law Appellate Tribunal (NCLAT) has been adjourned again. The scheduled hearing for September 18, 2025, could not proceed due to a lack of time available to the tribunal.

Repeated Adjournments

This marks the latest in a series of postponements for this matter. Previous hearing dates and adjournments include:

• November 23, 2021: Initial disclosure regarding the NCLAT order.
• May 12, 2022: Update on the time granted to submit notes.
• July 22, 2022: Filing of written submissions.
• September 9, 2022: Adjournment due to time constraints.
• December 7, 2022: Further adjournment.
• April 18, 2023: Adjournment and rescheduling.
• August 8, 2023: Another adjournment.
• November 2, 2023: Matter adjourned again.
• December 21, 2023: Additional postponement.
• February 2, 2024: Arguments commenced, matter listed again.
• March 11, 2024: Adjournment.
• April 8, 2024: Further adjournment.
• July 24, 2024: Subsequent postponement.
• September 3, 2024: Adjournment.
• December 5, 2024: Hearing postponed.
• February 7, 2025: Matter adjourned.
• April 14, 2025: Another adjournment.
• April 15, 2025: Hearing date set.
• April 30, 2025: Notification of new hearing date.
• May 14, 2025: Adjournment, new date pending.
• May 25, 2025: New hearing date listed.
• July 15, 2025: Matter adjourned.
• July 23, 2025: Matter posted for hearing.
• August 12, 2025: Adjournment, next date pending.
• August 22, 2025: Matter posted for hearing.

Next Steps

Maruti Suzuki will announce the new hearing date once it has been determined by the NCLAT.

Source: BSE

Mastek Limited has announced the resignation of Grant Thornton UK LLP as the statutory auditors of its UK subsidiary, Mastek (UK) Limited, effective September 18, 2025. Grant Thornton’s resignation, tendered via letter dated September 17, 2025, was due to the company not being reappointed after an audit tender process. The company has confirmed that all necessary disclosures and documentation have been provided.

Auditor Change at Mastek UK

Mastek Limited has announced a change in auditors for its material subsidiary, Mastek (UK) Limited. Grant Thornton UK LLP has resigned from its position as statutory auditors, effective September 18, 2025. The resignation was tendered via letter on September 17, 2025.

Reason for Resignation

According to the official statement, Grant Thornton UK LLP’s resignation resulted from the company not being reappointed following an audit tender process. The company affirms that there are no other material reasons for the resignation besides the stated one.

Additional Details

Mastek has confirmed compliance with the information requirements related to auditor resignations. All required information and documentation have been provided, and there were no outstanding concerns raised by Grant Thornton prior to their resignation.

Source: BSE

Reliance Industries has completed the amalgamation of Reliance Exploration & Production DMCC with Reliance Industries (Middle East) DMCC, effective September 16, 2025. Reliance Exploration & Production DMCC was a wholly owned subsidiary. The certificate of amalgamation was received on September 17, 2025. This move streamlines the company’s structure in the exploration and production sector.

Amalgamation Effective

Reliance Industries announced the successful amalgamation of Reliance Exploration & Production DMCC, a wholly owned subsidiary, with Reliance Industries (Middle East) DMCC. This came into effect on September 16, 2025.

Certificate of Amalgamation

The certificate confirming this amalgamation was received by the company on September 17, 2025, at 5:20 p.m. (IST). The company stated the action is for information and records.

Source: BSE

SBI Life has granted 8,30,000 stock options to eligible employees under the Employee Stock Option Scheme 2018 (ESOS). Each option allows allotment of one equity share at ₹10. Exercise price will be the lower of the Fair Market Value (FMV) on the grant date or the average FMV of the 15 trading days preceding the grant date. Vesting will commence one year from grant, at 30%-30%-40%.

Stock Option Grant Details

SBI Life Insurance Company has approved the grant of stock options under its Employee Stock Option Scheme 2018 (ESOS). The decision was made during a meeting of the Board Nomination and Remuneration Committee held on September 18, 2025.

Key Highlights of the ESOS Grant

• Total Options Granted: 8,30,000 options.
• Share Allotment: Each option entitles the holder to one equity share of ₹10.
• Vesting Schedule: Vesting will be in the proportion of 30%-30%-40%, beginning one year from the grant date.
• Exercise Period: Options can be exercised within 7 years from the grant date.
• Exercise Price: The exercise price is determined as the lower of two values: the Fair Market Value (FMV) on the grant date, or the average Fair Market Value over the 15 trading days immediately before the grant date.

Additional Information

The scheme aligns with the SEBI (Share Based Employees Benefits and Sweat Equity) Regulations, 2021.

Source: BSE

Great Eastern Shipping has announced that its wholly-owned subsidiary, Greatship (India) Limited (GIL), has secured a loan of ₹425 crore. This loan will be used by GIL to prepay its existing External Commercial Borrowing facility, which currently stands at USD 70.9 million. The inter-corporate loan carries an interest rate of 7.50% per annum and has a term of 2.5 years.

Loan Agreement Details

Great Eastern Shipping has entered into a loan agreement with its subsidiary, Greatship (India) Limited (GIL). This agreement, finalized on September 18, 2025, involves Great Eastern Shipping providing a loan of ₹425 crore to GIL. As a wholly-owned subsidiary, Great Eastern Shipping holds 100% of the shares in GIL.

Purpose of the Loan

The primary purpose of this inter-corporate loan is to enable Greatship (India) Limited to prepay its existing External Commercial Borrowing facility. The current outstanding amount for this facility is USD 70.9 million.

Key Terms of the Loan

The loan carries an interest rate of 7.50% per annum, payable quarterly. The term of the loan is set for 2.5 years, with a prepayment option available to GIL. The announcement confirms that the loan transaction is conducted on an arm’s length basis, ensuring fair terms for both parties.

Source: BSE

Sai Life Sciences has opened a new, dedicated facility (Unit VI) in Bidar, India, for the production of veterinary APIs. Located alongside its existing Unit IV, this expansion aims to meet growing demand for high-quality veterinary pharmaceuticals. The new facility incorporates advanced technologies and sustainable practices. Krishna Kanumuri, CEO, emphasized the company’s commitment to innovation and reliable solutions for animal well-being.

New Veterinary API Production

Sai Life Sciences has announced the opening of Unit VI in Bidar, India, a dedicated facility for veterinary API production. This facility, located with the company’s flagship API manufacturing site (Unit IV), focuses exclusively on producing APIs for veterinary applications. The announcement was made on September 18, 2025.

Facility Design and Objectives

The new facility is engineered to meet stringent safety, sustainability, and regulatory standards, ensuring the production of high-quality APIs for veterinary use. The company intends to provide efficient and scalable manufacturing solutions for leading global animal health companies. The investment aims to strengthen the ability to meet the increasing global need for high-quality veterinary pharmaceuticals.

Executive Commentary

Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences, noted that the investment enhances the company’s ability to meet global demand and uphold high standards of innovation, efficiency, and sustainability. The company aims to support its partners in delivering reliable solutions for animal well-being.

Strategic Alignment

The investment in the new facility aligns with Sai Life Sciences’ strategic vision to enhance its offerings in niche, high-value segments within the pharmaceutical industry. The facility is equipped with advanced technologies and leverages robust supply chain management and safety practices.

Source: BSE

IRB Infrastructure Developers will host a meeting/group meetings with investors/analysts on September 25, 2025. The meetings, hosted by J.P. Morgan, will involve senior management. No undisclosed price-sensitive information is expected to be shared. This event offers a platform for dialogue between the company and the investment community.

Investor Engagement Initiative

IRB Infrastructure Developers is set to engage with analysts and institutional investors through a series of meetings. These meetings are scheduled for September 25, 2025, offering an opportunity for the investment community to gain insights into the company’s strategy and performance.

Meeting Details

The senior management of IRB Infrastructure Developers will participate in the meeting/group meetings. J.P. Morgan will host the event, bringing together key stakeholders. According to the official release, the company does not anticipate sharing any undisclosed price-sensitive information during these discussions.

Purpose of the Meeting

The analyst/investor meeting aims to facilitate open communication between IRB Infrastructure Developers and the investment community. This interaction allows for a deeper understanding of the company’s operations and outlook. The company will use these meetings as a platform for dialogue with investors.

Source: BSE

IRB Infrastructure Developers Limited will host meetings with investors and analysts on September 23, 2025. These meetings will be conducted in a virtual or in-person format and hosted by Arihant Capital. The company confirmed that no unpublished price-sensitive information (UPSI) is expected to be shared during these discussions. The schedule is subject to change.

Investor Engagement Announcement

IRB Infrastructure Developers Limited has announced an upcoming schedule of meetings focused on engaging with both analysts and investors. These meetings represent an opportunity for stakeholders to gain insights into the company’s strategy and performance.

Meeting Details

The meetings are scheduled for September 23, 2025, and will be hosted by Arihant Capital. The format will accommodate both virtual and in-person participation for investors and analysts. The company has explicitly stated that no unpublished price-sensitive information (UPSI) will be disclosed during the course of these meetings. The meeting schedule remains subject to potential changes.

Source: BSE

Godawari Power & Ispat has issued a corrigendum to its board meeting outcome dated September 18, 2025, concerning the preferential issue of convertible warrants. The correction pertains to the spelling of certain investor names listed in Annexure A of the original announcement. This update ensures accuracy in investor details related to the fund-raising initiative.

Corrigendum to Board Outcome

Godawari Power & Ispat (GPIL) has released a corrigendum concerning its board meeting outcome from September 18, 2025. This update addresses inaccuracies in the spelling of investor names associated with the preferential issue of convertible warrants, as detailed in the initial announcement.

Investor Name Corrections

The corrigendum specifically revises the spelling of investor names in Annexure A of the original board meeting outcome. The following corrections have been made:

• Incorrect: Mrs Sarita Agrawal; Correct: Mrs Sarita Devi Agrawal
• Incorrect: Shree Nakoda Pipes Impex Private Limited; Correct: Shree Nakoda Pipe Impex Private Limited
• Incorrect: Meridian Realtech Private Limited; Correct: Meridien Realtech Private Limited

The company clarified that these were the only corrections required in the outcome, ensuring accurate records of the investors involved.

Details of Warrant Issuance

The original announcement detailed the proposed issuance of up to 2,04,08,220 warrants, convertible into equity shares, aiming to raise an aggregate amount of ₹500,00,13,900. Each warrant is convertible into one equity share and can be exercised within 18 months from the allotment date.

Shareholding Pattern

Post-allotment, assuming full conversion of warrants, the promoter and promoter group shareholding will be 63.05%, while the public shareholding will be 36.95%.

Source: BSE

Oil India Limited has successfully convened its 66th Annual General Meeting on September 18, 2025, at 11:00 AM. A presentation related to the Post AGM Press Meet is now available on the company’s website. This announcement is for informational purposes and record-keeping.

Annual General Meeting Update

Oil India Limited has announced the successful completion of its 66th Annual General Meeting (AGM) held on September 18, 2025, at 11:00 AM.

Post AGM Presentation Available

Following the AGM, the company has made available a presentation related to the Post AGM Press Meet. The presentation has been uploaded and can be accessed through the company’s official website.

The presentation provides insights into the company’s performance, future strategies, and key developments. Stakeholders are encouraged to review the presentation for detailed information.

Source: BSE